The UnderWhelming season of Anthony Volpe for the New York Yankees has made the Shortstop a topic of controversy in the Bronx, and more attention was generated this week when he was revealed that Volpe plays with a small tear in his left shoulder Labrum since 3 May. The previously excellent defense of Volpe has drastically lost weight.
Yankees GM Brian Cashman spoke with Jorge Castillo of ESP on Friday, Cashman gave a voice of confidence to Volpe and said that the 2025 season “our position does not change about what it is capable of”, and that he is still the choice of the Yankees at Shortstop.
“He is someone we can count on and we believe in … I think he is a real talented man and I think he has the chance to have a positive impact,” Cashman said.
Volpe struck considerably better (.239/.333/.453) in his first 135 plate performances of the pre-injury season, so it could be that his Labrum tear appeared a potential breakout year. Yet the numbers of Volpe are not far from the .228/.288/.373 sloping line that he placed more than 1290 PA in his first two Major League seasons, so it is not as if struggles on the plate are a new problem for the 24-year-old.
‘Next Derek Jeter’ Hype did not help New York Yankees’ Anthony Volpe
The expectations of reflective expectations have been followed since his rise as one of the best prospects of baseball, and the decision of the Yankees to make him debut as their opening day Shortstop in 2023. Although the team itself has always been fast to play the “next Derek Jeter” hype, the most top contrast of the all kinds of contrast. in recent years. If there is something, the critics of Volpe will certainly claim that Cashman’s constant trust in Volpe is part of the problem and that the Yankees should be more open to upgrading at Shortstop.
Although Cashman has made a number of rather blunt criticism of other New York players in the past, it is only logical for the GM to continue his public support of Volpe, and there is no reason to suspect that the Yankees does not view the tough year of Volpe as something other than a by-product of his shoulder injury. Since Volpe is only eligible for arbitration that is eligible outside the season, his three remaining years of fairly cheap team control make him an intriguing one in a team that meets large salaries and a considerable luxury tax assessment. If Volpe is able to become healthy and break out, such as in the words of Cashman, “a quality, above -average regular shortstop in the game”, that is an important boost for the Yankees on every front.
Yet finding another cheap candidate for shortstop could change the comparison, and such a player may already have been found in Jose Caballero. Acquired of the rays at the Handelsdeadline, Caballero .263/.358/.439 in 68 PA in the pinstripes, which represents the best offensive piece of his three MLB seasons far and away. The Utilityman was also thrown on both corner field slots, the second base and the third base, but most of the time of Caballero came on Shortstop after the increased time of Volpe.
Volpe has not played since Tuesday after he had received a Cortisone shot in his distressed shoulder, so Caballero released the way to get into the regular Shortstop service. Boone told Castillo and Company that “we will see” about who plays shortstop when Volpe is ready to return, which indicates that the Yankees could consider a Timeshare in the position.
The problem in the longer term of Volpe health is also a persistent question. Cashman said that more will be known as soon as full more tests will receive, and while the GM would “exclude” an operation from the season “exclude”, “from now on there is no operation recommended. No Il is recommended.” If Volpe does indeed go under the knife, he would most likely miss some time and perhaps a longer amount of the 2026 season, so that the Yankees need another short stop.
#Cashman #Yankees #Anthony #Volpe #tough #stretch